Pires da Silva, I., Ahmed, T., McQuade, J. L., Nebhan, C. A., Park, J. J., Versluis, J. M., . . . Menzies, A. M. (2022). Clinical models to define response and survival with anti-PD-1 antibodies alone or combined with ipilimumab in metastatic melanoma. Journal of clinical oncology, 40(10), . https://doi.org/10.1200/JCO.21.01701
Chicago-Zitierstil (17. Ausg.)Pires da Silva, Inês, et al. "Clinical Models to Define Response and Survival with Anti-PD-1 Antibodies Alone or Combined with Ipilimumab in Metastatic Melanoma." Journal of Clinical Oncology 40, no. 10 (2022). https://doi.org/10.1200/JCO.21.01701.
MLA-Zitierstil (9. Ausg.)Pires da Silva, Inês, et al. "Clinical Models to Define Response and Survival with Anti-PD-1 Antibodies Alone or Combined with Ipilimumab in Metastatic Melanoma." Journal of Clinical Oncology, vol. 40, no. 10, 2022, https://doi.org/10.1200/JCO.21.01701.